|
1
|
Shakked RJ, Geller DS, Gorlick R and
Dorfman HD: Mesenchymal chondrosarcoma: clinicopathologic study of
20 cases. Arch Pathol Lab Med. 136:61–75. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weiss SW and Goldblum JR: Enzinger and
Weiss’s Soft Tissue Tumors. Mosby; St Louis, MO: 2001
|
|
3
|
Riedel RF, Larrier N, Dodd L, Kirsch D,
Martinez S and Brigman BE: The clinical management of
chondrosarcoma. Curr Treat Options Oncol. 10:94–106. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cesari M, Bertoni F, Bacchini P, Mercuri
M, Palmerini E and Ferrari S: Mesenchymal chondrosarcoma. An
analysis of patients treated at a single institution. Tumori.
93:423–427. 2007.PubMed/NCBI
|
|
5
|
Dantonello TM, Int-Veen C, Leuschner I, et
al: Mesenchymal chondrosarcoma of soft tissues and bone in
children, adolescents, and young adults: experiences of the CWS and
COSS study groups. Cancer. 112:2424–2431. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Crosswell H, Buchino JJ, Sweetman R and
Reisner A: Intracranial mesenchymal chondrosarcoma in an infant.
Med Pediatr Oncol. 34:370–374. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dobin SM, Donner LR and Speights VO Jr:
Mesenchymal chondrosarcoma. A cytogenetic, immunohistochemical and
ultrastructural study. Cancer Genet Cytogenet. 83:56–60. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fletcher CD, Dal Cin P, de Wever I, et al:
Correlation between clinicopathological features and karyotype in
spindle cell sarcomas. A report of 130 cases from the CHAMP study
group. Am J Pathol. 154:1841–1847. 1999. View Article : Google Scholar
|
|
9
|
Gatter KM, Olson S, Lawce H and Rader AE:
Trisomy 8 as the sole cytogenetic abnormality in a case of
extraskeletal mesenchymal chondrosarcoma. Cancer Genet Cytogenet.
159:151–154. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mandahl N, Gustafson P, Mertens F, et al:
Cytogenetic aberrations and their prognostic impact in
chondrosarcoma. Genes Chromosomes Cancer. 33:188–200. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Naumann S, Krallman PA, Unni KK, Fidler
ME, Neff JR and Bridge JA: Translocation der(13;21)(q10;q10) in
skeletal and extraskeletal mesenchymal chondrosarcoma. Mod Pathol.
15:572–576. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nyquist KB, Panagopoulos I, Thorsen J, et
al: Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1
fusion gene brought about by translocation t(1;5)(q42;q32) in
mesenchymal chondrosarcoma. PLoS One. 7:e497052012. View Article : Google Scholar
|
|
13
|
Richkind KE, Romansky SG and Finklestein
JZ: t(4;19)(q35;q13.1): a recurrent change in primitive mesenchymal
tumors? Cancer Genet Cytogenet. 87:71–74. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sainati L, Scapinello A, Montaldi A, et
al: A mesenchymal chondrosarcoma of a child with the reciprocal
translocation (11;22)(q24;q12). Cancer Genet Cytogenet. 71:144–147.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Szymanska J, Tarkkanen M, Wiklund T, et
al: Cytogenetic study of extraskeletal mesenchymal chondrosarcoma.
A case report. Cancer Genet Cytogenet. 86:170–173. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang L, Motoi T, Khanin R, et al:
Identification of a novel, recurrent HEY1-NCOA2 fusion in
mesenchymal chondrosarcoma based on a genome-wide screen of
exon-level expression data. Genes Chromosomes Cancer. 51:127–139.
2012. View Article : Google Scholar
|
|
17
|
Mandahl N: Methods in solid tumour
cytogenetics. Human Cytogenetics: Malignancy and Acquired
Abnormalities. Rooney DE: Oxford University Press; New York: pp.
165–203. 2001
|
|
18
|
Schaffer LG, Slovak ML and Campbell LJ:
ISCN 2009: An International System for Human Cytogenetic
Nomenclature. Karger; Basel: 2009
|
|
19
|
Nakayama R, Miura Y, Ogino J, et al:
Detection of HEY1-NCOA2 fusion by fluorescence in-situ
hybridization in formalin-fixed paraffin-embedded tissues as a
possible diagnostic tool for mesenchymal chondrosarcoma. Pathol
Int. 62:823–826. 2012. View Article : Google Scholar
|
|
20
|
Carapeti M, Aguiar RC, Goldman JM and
Cross NC: A novel fusion between MOZ and the nuclear receptor
coactivator TIF2 in acute myeloid leukemia. Blood. 91:3127–3133.
1998.PubMed/NCBI
|
|
21
|
Carapeti M, Aguiar RC, Watmore AE, Goldman
JM and Cross NC: Consistent fusion of MOZ and TIF2 in AML with
inv(8)(p11q13). Cancer Genet Cytogenet. 113:70–72. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Strehl S, Nebral K, Konig M, et al:
ETV6-NCOA2: a novel fusion gene in acute leukemia associated with
coexpression of T-lymphoid and myeloid markers and frequent NOTCH1
mutations. Clin Cancer Res. 14:977–983. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sumegi J, Streblow R, Frayer RW, et al:
Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma
without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear
receptor transcriptional coactivator family. Genes Chromosomes
Cancer. 49:224–236. 2010.
|
|
24
|
Arbajian E, Magnusson L, Mertens F,
Domanski HA, Vult von Steyern F and Nord KH: A novel GTF2I/NCOA2
fusion gene emphasizes the role of NCOA2 in soft tissue
angiofibroma development. Genes Chromosomes Cancer. 52:330–331.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jin Y, Möller E, Nord KH, et al: Fusion of
the AHRR and NCOA2 genes through a recurrent translocation
t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation
of aryl hydrocarbon receptor target genes. Genes Chromosomes
Cancer. 51:510–520. 2012. View Article : Google Scholar
|
|
26
|
Mosquera JM, Sboner A, Zhang L, et al:
Recurrent NCOA2 gene rearrangements in congenital/infantile spindle
cell rhabdomyosarcoma. Genes Chromosomes Cancer. 52:538–550. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deguchi K, Ayton PM, Carapeti M, et al:
MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome
binding motif and TIF2-mediated recruitment of CBP. Cancer Cell.
3:259–271. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhuravleva J, Paggetti J, Martin L, et al:
MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish. Br J
Haematol. 143:378–382. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Steidl C, Leimeister C, Klamt B, et al:
Characterization of the human and mouse HEY1, HEY2, and HEYL genes:
cloning, mapping, and mutation screening of a new bHLH gene family.
Genomics. 66:195–203. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maier MM and Gessler M: Comparative
analysis of the human and mouse Hey1 promoter: Hey genes are new
Notch target genes. Biochem Biophys Res Commun. 275:652–660. 2000.
View Article : Google Scholar : PubMed/NCBI
|
